Patent · US Active

Inhibitors of bruton's tyrosine kinase

US9012463B2 · kind B2 · utility

40Cited by
6References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 12, 2010
Grant dateApr 21, 2015
Priority date—
Expiry dateJun 25, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described herein are kinase inhibitor compounds of Formula IV:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.